Skip to main content
SpringerLink
Log in

Development of Parainfluenza Virus and Respiratory Syncytial Virus Subunit Vaccines

  • Chapter
Vaccine Design

Part of the book series: NATO ASI Series ((NSSA,volume 293))

  • 123 Accesses

Abstract

Human respiratory syncytial virus (RSV) (McIntosh and Chanock, 1990) and parainfluenza virus (PIV) types 1,2,3 (Chanock and Mclntosh, 1990) have been identified as the major viral pathogens responsible for severe respiratory tract infections in infants and young children. In the United States alone, approximately 4,500 infants and young children are expected to die each year as a result of severe respiratory tract infections caused by RSV (Katz, 1985). The global annual infection and mortality figures for RSV are estimated to be 65 million and 160,000, respectively (Robbins and Freeman, 1988). Recent epidemiological data has indicated that RSV also causes significant morbidity and mortality in the elderly (Falsey et al, 1995), the immunocompromised (Englund et al., 1988) as well as in hospitalized adults with lower respiratory tract infections (Dowell et al., 1996). With respect to the parainfluenza viruses, PIV-3 is second only to RSV as the causative agent of bronchiolitis and pneumonia in infants less than 6 months of age. Annually, approximately 1,000 infants may die in the United States from severe respiratory tract infections caused by PIV-3. Furthermore, it is estimated that 600,000 children under the age of 6 develop laryngotracheobronchitis (croup) each year as a result of infection with PIV-1 and 2 (Katz, 1985). It has also been recently reported that the parainfluenza viruses can cause life threatening pneumonia in adult bone marrow transplant recipients (Lewis et al., 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ambrose, M.W., Wyde, P., Ewasyshyn, M., Bonneau, A.-M., Caplan, B., Meyer, H.L. and Klein, M., 1991, Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats, Vaccine. 9: 505.

    Article  PubMed  CAS  Google Scholar 

  • Belshe, R.B., Anderson, E.L. and Walsh, E.E., 1993, Immunogenicity of purified Flycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children, J. Infect. Dis., 168: 1024.

    Article  PubMed  CAS  Google Scholar 

  • Brideau, R.J., Walters, R.R., Stier, M.A. and Wathen, M.W., 1989, Protection of cotton rats against human respiratory virus by vaccination with a novel chimeric FG glycoprotein, J.Gen.Virol., 70: 2637.

    Article  PubMed  CAS  Google Scholar 

  • Chanock, R.M. and McIntosh, K., 1990, Parainfluenza viruses, in: “Virology”, B.N. Fields, and D.M. Knipe, eds., Raven Press, New York.

    Google Scholar 

  • Chin, J., Magoffin, R.L., Shearer, L.A., Schieble, J.H. and Lennette, E.H., 1969, Field valuation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population, Am. J. Epidemiol. 89: 449.

    PubMed  CAS  Google Scholar 

  • Connors, M., Collins, P.L., Firestone, C.-Y., Sotnikov, A.V., Waitze, A., Davis, A.R., Hung, P.P., Chanock, R.M. and Murphy, B., 1992, Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV, Vaccine. 10: 475.

    Article  PubMed  CAS  Google Scholar 

  • Connors, M., Giese, N.A., Kulkarni, A.B., Firestone, C.Y., Morse, H.C., Sotnikov, A.V. and Murphy, B.R., 1992, Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ cells, J. Virol. 66: 7444.

    PubMed  CAS  Google Scholar 

  • Connors, M., Giese, A.B., Firestone, C.Y., Morse, H.C. and Murphy, B.R., 1994, Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (1L-4) and IL-10. J. Virol. 68: 5321.

    PubMed  CAS  Google Scholar 

  • Dowell, S.F., Anderson, L.J., Gary, H.E., Erdman, D.D., Plouffe, J.E., File, T.M., Marston, B.J. and Breiman, R.F., 1996, Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults, J. Infect. Dis., 174: 456.

    Article  PubMed  CAS  Google Scholar 

  • Du, R-P., Jackson, E.D., Wyde, P.R., Yan, W.-Y., Wang, Q., Gissoni, L., Sanhueza, S.E., Klein, M.H. and Ewasyshyn, M.E., 1994, A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3, Biotechnology. 12: 813.

    Article  PubMed  CAS  Google Scholar 

  • Englund, J.A., Sullivan, C.J., Jordan, M.C., Dehner, L.P., Vercellotti, G.M. and Balfour, H.H., 1988, Respiratory syncytial virus infection in immunocompromised adults, Ann. Intern. Med., 109: 203.

    Article  PubMed  CAS  Google Scholar 

  • Ewasyshyn, M., Caplan, B., Bonneau, A.-M., Scollard, N., Graham, S., Usman, S. and Klein, M., 1992, Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine, Vaccine. 10: 412.

    Article  PubMed  CAS  Google Scholar 

  • Ewasyshyn, M.E., Bonneau, A.-M., Usman, S., Scollard, N. and Klein, M., 1993, Comparative analysis of the immunoprotective abilities of glycosylated and deglycosylated parainfluenza virus type 3 surface glycoproteins. J. Gen. Virol., 74: 2781.

    Article  PubMed  CAS  Google Scholar 

  • Ewasyshyn, M.E. and Klein, M., 1994, “Development of Paramyxoviridae vaccines”, in: Modern Vaccinology, E. Kurstak, ed., Plenum Publishing Corporation, New York.

    Google Scholar 

  • Falsey, A.R., Cunningham, C.K. and Barker, W.H., 1995, Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis., 172: 389.

    Article  PubMed  CAS  Google Scholar 

  • Fulginiti, V.A., Eller, J.J., Siever, O.F., Joyner, J.W., Minamitani, M. and Meiklejohn, G., 1969, respiratory virus immunization. A field trial of two inactivated virus vaccines: an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol., 89: 435.

    PubMed  CAS  Google Scholar 

  • Graham, B. S., Henderson, Y.-W., Tang, S., Lu, Neuzil, K.M. and Colley, D.G., 1993, Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus, J. Immunol., 151: 2032.

    PubMed  CAS  Google Scholar 

  • Hancock, G. E., Speelman, D.J., Frenchick, P.J., Mineo-Kuhn, M.M., Baggs, R.B. and Hahn, D., 1995, Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection, Vaccine. 13: 391.

    Article  PubMed  CAS  Google Scholar 

  • Hildreth, S.W., Baggs, R.R., Brownstein, D.G., Castleman, W.L. and Paradiso, P.R., 1993, Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3–6 months after immunization, Vaccine, 11: 615.

    Article  PubMed  CAS  Google Scholar 

  • Homa, F.L., Brideau, R. J., Lehman, D.J., Thomsen, D. R., Olmsted, R.A. and Wathen, M.W., 1993, Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. J. Gen. Virol., 74: 1995.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, P.R., Olmsted, R.a., Prince, G.A., Murphy, B.R., Ailing, D.W., Walsh, E.E. and Collins, P.L., 1987, Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of the F and G glycoproteins to immunity. J. Virol., 61: 3163.

    PubMed  CAS  Google Scholar 

  • Kakuk, T. J., Soike K., Brideau, R. J., Zaya, R. M., Cole, S.L., Zhang, J.-Y., Roberts, E.D., Wells, P.A. and Wathen, M.W., 1993, A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formal in-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J. Infect. Dis., 167: 553.

    Article  PubMed  CAS  Google Scholar 

  • Katz, S.L. 1985, Prospects for immunizing against parainfluenza and respiratory synyctial viruses, in: “New Vaccine Development Establishing Priorities”, National Academic Press, Washington.

    Google Scholar 

  • Lewis, V.A., Champlin, R., Englund, J., Couch, R., Goodrich, J.M., Rolston, K., Przepiorka, D., Mirza, N.Q., Yousuf, H.A., Luna, M., Bodey, G.P. and Whimbey, E., 1996, Respiratory diseases due to parainfluenza virus in adult bone marrow transplant recipients. Clinical Infect. Dis., 23: 1033.

    Article  CAS  Google Scholar 

  • McIntosh, K. and Chanock, R.M., 1990, Respiratory syncytial virus, in: “Virology”, B. N. Fields, and D.M. Knipe, eds., Raven Press, New York.

    Google Scholar 

  • Murphy, B.R., Sotnikov, A., Paradiso, P.R., Hildreth, S.W., Jenson, A.B., Baggs, R.B., Lawrence, L., Zubak, J.J. Chanock, R.M., Beeler, J.A. and Prince, G.A., 1989, Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease, Vaccine. 7: 533.

    Article  PubMed  CAS  Google Scholar 

  • Murphy, B.R., Sotnikov, A., Lawrence, L., Banks, S. and Prince, G., 1990, Enhanced histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization, Vaccine, 8: 497.

    Article  PubMed  CAS  Google Scholar 

  • Pemberton, R.M., Cannon, M.J., Openshaw, L.A., Ball, G.W., Wertz, G.W. and Askonas, A., 1987. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen, J. Gen. Virol., 68: 2177.

    Article  PubMed  CAS  Google Scholar 

  • Piedra, P.A., Camussi, F. and Ogra, P.L., 1989. Immune response to experimentally induced infections with respiratory syncytial virus: possible role in the development of pulmonary disease, J.Gen.Virol., 70: 325.

    Article  PubMed  Google Scholar 

  • Piedra, P.A., Grace, S., Jewell, Al., Spinelli, S., Bunting, D., Hogerman, D.A., Malinoski, F. and Hiatt, P.W., 1996, Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis, Pediatr. Infect. Dis.J., 15: 23.

    Article  PubMed  CAS  Google Scholar 

  • Robbins, A. and Freeman, P., 1988, Obstacles for developing vaccines for the third world. Sci.Am. 259: 126.

    Article  PubMed  CAS  Google Scholar 

  • Sanz, M. C., Kew, O.M. and Anderson, L.J., 1994, Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses, Virus Research. 33: 203.

    Article  PubMed  CAS  Google Scholar 

  • Spriggs, M.K., Murphy, B.R., Prince, G.A., Olmsted, R.A. and Collins, P.L., 1987, Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity, J. Virol., 61: 3416.

    PubMed  CAS  Google Scholar 

  • Tristam, D.A., Welliver, R.C., Mohar, C.K., Hogerman, D.A., Hildreth, S.W. and Paradiso, P., 1993, Immunogenicity and safety of respiratory synyctial virus subunit vaccine in seropositive children 18–36 months old. J. Infect. Dis., 167: 191.

    Article  Google Scholar 

  • Vaux-Peretz, F., Chapsal, J.-M. and Meignier, B., 1992, Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G, and N proteins and cell lysates to enhance pulmonary changes in BALB/c mice, Vaccine. 10: 113.

    Article  PubMed  CAS  Google Scholar 

  • Walsh, E.E. and Hruska, J., 1983. Monoclonal antibodies to respiratory syncytial virus proteins identification of the fusion protein, J. Virol., 47: 171.

    PubMed  CAS  Google Scholar 

  • Walsh, E.E., Hall, C.B., Briselli, M., Brandriss, M.W. and Schlesinger, J.J., 1987, Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection, J. Infect. Dis., 155: 1198.

    Article  PubMed  CAS  Google Scholar 

  • Waris, M.E., Tsou, P., Erdman, P.P., Zaki, S. and Anderson, L.J., 1996, Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induced enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern, J. Virol., 70: 2852.

    PubMed  CAS  Google Scholar 

  • Wathen, M.W., Brideau, R.J. and Thomsen, P.R., 1989a, Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector, J. Infect. Dis., 159: 255.

    Article  PubMed  CAS  Google Scholar 

  • Wathen, M.W., Brideau, R.J. and Thomsen, D.R., 1989b, Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector, J. Gen. Virol., 70: 2625.

    Article  PubMed  CAS  Google Scholar 

  • Wathen, M.W., Kakuk, T.J., Brideau, R. J., Hausknecht, E.D., Cole, S.L. and Zaya, R.M., 1991, Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge, J. Infect. Dis., 163: 477.

    Article  PubMed  CAS  Google Scholar 

  • Wertz, G.W. and Sullender, W.M., 1992, Approaches to immunization against respiratory syncytial virus, Biotechnology. 20: 151.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Connaught Centre for Biotechnology Research, Pasteur Mérieux Connaught Canada, 1755 Steeles Ave. W., North York, Ontario, Canada, M2R 3T4

    M. Ewasyshyn, G. Cates, N. Scollard, R. P. Du & M. Klein

  2. Connaught Product Development Centre, Pasteur Mérieux Connaught Canada, 1755 Steeles Ave. W., North York, Ontario, Canada, M2R 3T4

    G. Jackson & A. Symington

Authors
  1. M. Ewasyshyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Cates
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Symington
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Scollard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. P. Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of London, London, England

    Gregory Gregoriadis  & Brenda McCormack  & 

  2. Dawa Corporation, Belmont, California, USA

    Anthony C. Allison

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ewasyshyn, M. et al. (1997). Development of Parainfluenza Virus and Respiratory Syncytial Virus Subunit Vaccines. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccine Design. NATO ASI Series, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0062-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0062-3_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0064-7

  • Online ISBN: 978-1-4899-0062-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation